WILSON TROY EDWARD enters ATRIUM THERAPEUTICS, INC. with 11.73K shares across direct and indirect positions
This filing by WILSON TROY EDWARD establishes the baseline for all future Form 4 insider transaction reports at ATRIUM THERAPEUTICS, INC..
Direct Indirect
Filed: 2/26/2026ACC: 0001193125-26-077934
Director
Since Feb 2026
11.73K
Baseline shares
88% direct
10.36K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
2
Security positions
1.37K indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned10.36K
Common Stock
IndirectShares owned1.37K
Total
10.36K direct·1.37K indirect11.73K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.36K | Direct |
| Common Stock | 1.37K | Indirect |
| Total | 11.73K | 10.36K direct·1.37K indirect |
Derivative Holdings0
No derivative holdings reported